Premature Ovarian Failure (POF) syndrome: Towards the molecular clinical analysis of its genetic complexity

被引:45
作者
Fassnacht, W
Mempel, A
Strowitzki, T
Vogt, PH [1 ]
机构
[1] Univ Womens Hosp, Dept Gynecol Endocrinol & Reprod Med, Heidelberg, Germany
[2] Univ Hosp Munster, Dept Obstet & Gynecol, Munster, Germany
关键词
POF-syndrome; Turner-syndrome; POF loci and key genes; human folliculogenesis;
D O I
10.2174/092986706776872943
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Premature Ovarian Failure (POF) syndrome is a very heterogeneous clinical disorder due probably to the complex genetic networks controlling human folliculogenesis. Clinical subgroups of POF patients whose aetiology of ovarian failure is based on the same genetic factors are therefore difficult to establish. Some experimental evidence suggests that these genes might be clustered on the female sex chromosome in the POF1 and POF2 loci. This review is aimed to present an overview of the actual structural changes of the X chromosome causing POF, and to present a number of X and autosomal female fertility genes which are probably key genes in human folliculogenesis and are therefore prominent POF candidate genes. Towards the molecular analysis of their functional contribution to the genetic aetiology of POF in the clinic, an interdisciplinary scheme for their diagnostic analysis is presented in a pilot study focussed on chromosome analyses and the expression analysis of some major POF candidate genes (DAZL, DBX, FOXL2, INH alpha, GDF9, USP9X) in the leukocytes of 101 POF patients. It starts with a comprehensive and significantly improved clinical diagnostic program for this large and heterogenous patient group.
引用
收藏
页码:1397 / 1410
页数:14
相关论文
共 121 条
  • [1] Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis
    Aaltonen, J
    Laitinen, MP
    Vuojolainen, K
    Jaatinen, R
    Horelli-Kuitunen, N
    Seppä, L
    Louhio, H
    Tuuri, T
    Sjöberg, J
    Bützow, R
    Hovatta, O
    Dale, L
    Ritvos, O
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08) : 2744 - 2750
  • [2] The human DDX and DHX gene families of putative RNA helicases
    Abdelhaleem, M
    Maltais, L
    Wain, H
    [J]. GENOMICS, 2003, 81 (06) : 618 - 622
  • [3] NUCLEUS BASALIS MAGNOCELLULARIS AND HIPPOCAMPUS ARE THE MAJOR SITES OF FMR-1 EXPRESSION IN THE HUMAN FETAL BRAIN
    ABITBOL, M
    MENINI, C
    DELEZOIDE, AL
    RHYNER, T
    VEKEMANS, M
    MALLET, J
    [J]. NATURE GENETICS, 1993, 4 (02) : 147 - 153
  • [4] Oocyte-specific gene signaling and its regulation of mammalian reproductive potential
    Acevedo, N
    Smith, GD
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 2335 - 2345
  • [5] CLINICAL VARIATION OF AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY (APECED) IN A SERIES OF 68 PATIENTS
    AHONEN, P
    MYLLARNIEMI, S
    SIPILA, I
    PERHEENTUPA, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (26) : 1829 - 1836
  • [6] AITTOMAKI K, 1994, AM J HUM GENET, V54, P844
  • [7] Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene
    Aittomaki, K
    Herva, R
    Stenman, UH
    Juntunen, K
    Ylostalo, P
    Hovatta, O
    delaChapelle, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) : 3722 - 3726
  • [8] MUTATION IN THE FOLLICLE-STIMULATING-HORMONE RECEPTOR GENE CAUSES HEREDITARY HYPERGONADOTROPIC OVARIAN FAILURE
    AITTOMAKI, K
    LUCENA, JLD
    PAKARINEN, P
    SISTONEN, P
    TAPANAINEN, J
    GROMOLL, J
    KASKIKARI, R
    SANKILA, EM
    LEHVASLAIHO, H
    ENGEL, AR
    NIESCHLAG, E
    HUHTANIEMI, I
    DELACHAPELLE, A
    [J]. CELL, 1995, 82 (06) : 959 - 968
  • [9] Al-Hendy A, 2000, LANCET, V356, P914
  • [10] A study of the distributional characteristics of FMR1 transcript levels in 238 individuals
    Allen, EG
    He, WY
    Yadav-Shah, M
    Sherman, SL
    [J]. HUMAN GENETICS, 2004, 114 (05) : 439 - 447